• Lung cancer deaths have been falling by nearly 5% a year since 2001 thanks to better treatment

    1 month ago - By Daily Mail

    A new study from the National Cancer Institute found, in men, deaths from non-small lung cancer fell by 6.3% per year from 2013 to 2016, while they fell by 5.9% annually in women from 2014 to 2016.
    Read more ...

     

  • Non-small cell lung cancer mortality rates decline sharply amid advances in treatment

    Non-small cell lung cancer mortality rates decline sharply amid advances in treatment

    1 month ago - By Healio

    Non-small cell lung cancer mortality decreased substantially among the general U.S. population between 2013 and 2016, according to results of a retrospective study published in The New England Journal of Medicine.
    The decline likely can be explained by a reduction in NSCLC incidence, as well as advances in treatment, including the introduction of targeted therapies, researchers noted.
    “No one is discounting the role that decreased rates of smoking over many years in the United States has had on the falling mortality over time, but our research brings to light some other important factors,”
    Read more ...

     

  • Sintilimab plus pemetrexed, chemotherapy extends PFS in non-small cell lung cancer subset

    1 month ago - By Healio

    The addition of sintilimab to pemetrexed and platinum chemotherapy conferred a significant PFS benefit for a subset of patients with nonsquamous non-small cell lung cancer, according to results of an interim analysis of the ORIENT-11 study.
    Researchers observed the benefit specifically among patients with locally advanced or metastatic disease and no EGFR or ALK mutations.
    Li Zhang, MD, researcher at Sun Yat-sen University Cancer Center in China, presented the results during the International Association for the Study of Lung Cancer World Conference on Lung Cancer Virtual Presidential
    Read more ...